サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1594913

タンパク質工学の世界市場

Protein Engineering

出版日
ページ情報
英文 81 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
タンパク質工学の世界市場
出版日: 2024年11月22日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 81 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

タンパク質工学の世界市場は2030年までに78億米ドルに到達

2023年に30億米ドルと推定されるタンパク質工学の世界市場は、2030年には78億米ドルに達し、分析期間2023-2030年のCAGRは14.5%で成長すると予測されます。タンパク質工学器械は、本レポートで分析したセグメントの1つであり、CAGRは13.8％を記録し、分析期間終了時には33億米ドルに達すると予測されています。タンパク質工学試薬セグメントの成長率は、分析期間でCAGR 14.7％と推定されます。

米国市場は7億7,990万米ドルと推定、中国はCAGR18.9％で成長予測

米国のタンパク質工学市場は、2023年に7億7,990万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2023-2030年のCAGR18.9%で推移し、2030年までに20億米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ10.0％と12.2％と予測されています。欧州では、ドイツがCAGR 10.9%で成長すると予測されています。

世界のタンパク質工学市場- 主要動向と促進要因のまとめ

タンパク質工学はバイオ医薬品の未来をどのように形成しているのか？

タンパク質工学は、有効性、安定性、標的特異性を高めたオーダーメイドの治療用タンパク質の開発を可能にすることで、バイオ医薬品に革命をもたらしています。タンパク質の構造を操作することで、科学者はモノクローナル抗体、酵素、その他の治療用タンパク質を、特定の疾患の治療に最適化された特性で作り出すことができます。例えば、モノクローナル抗体は、がん、自己免疫疾患、感染症との闘いにおいて、オフターゲット効果を低減し、患者の転帰を改善する標的療法を提供する貴重なものとなっています。同様に、酵素補充療法もタンパク質工学の応用の一つであり、ゴーシェ病やファブリー病のような遺伝性疾患の治療に不可欠です。タンパク質工学がワクチン開発に与える影響も大きく、操作されたタンパク質はウイルスの脅威に対するワクチンに使用され、免疫反応や様々なデリバリー形式での安定性を高めています。タンパク質を分子レベルでカスタマイズできる可能性があることから、タンパク質工学は、治療が個人の遺伝的体質に合わせて行われるようになり、治療の成功率が高まり、副作用が減少する精密医療の要として位置づけられています。バイオ製薬会社が標的療法を追求し続ける中、タンパク質工学は最前線に立ち、革新的な医薬品や治療法をより早く、より有効性の高いものとして市場に送り出すお手伝いをしています。

タンパク質工学のイノベーションにおいて、合成生物学はどのような役割を果たしていますか？

合成生物学はタンパク質工学の強力なツールとなっており、研究者は特定の産業、環境、医療ニーズに対応する新規機能性タンパク質をデザインすることができます。CRISPRやTALENのような遺伝子編集技術の進歩により、タンパク質の構造を正確に改変することが容易になり、新たな機能を生み出し、タンパク質工学の用途を広げています。合成生物学はまた、産業プロセスで使用される持続可能な酵素の開発を推進し、過酷な化学物質を環境に優しい生体触媒に置き換えています。例えば、繊維産業、洗剤産業、バイオ燃料産業では、人工酵素が広く使用されるようになり、エネルギー消費の削減、廃棄物の削減、効率の向上に役立っています。さらに、計算モデルやハイスループットスクリーニングを取り入れることで、合成生物学は、極端な温度やpHレベルといった厳しい条件下で、より高い安定性と機能性を示すタンパク質を科学者が作り出すことを可能にしています。このように設計されたタンパク質は、環境浄化においても有用であることが証明されつつあり、汚染物質を分解したり二酸化炭素を回収したりするように設計されたタンパク質が、環境破壊を緩和するために導入されています。合成生物学とタンパク質工学の相乗効果により、タンパク質はイノベーションの可能性を広げ、想像しうるあらゆる用途に設計できるようになり、あらゆる産業で不可欠なものとなっています。

AIと機械学習はタンパク質工学をどのように変革するのか？

AIと機械学習は、設計と最適化のプロセスを大幅にスピードアップすることで、タンパク質工学を変革しています。従来、タンパク質工学は、望ましいタンパク質の特性を達成するために数え切れないほどの反復を必要とする、時間のかかる分野でした。しかし、AIアルゴリズムの導入により、データ駆動型の予測を使ってタンパク質の挙動をモデル化することで、この複雑さが劇的に軽減され、研究者は構造的相互作用や修飾を驚くほどの精度で予見できるようになりました。タンパク質データで訓練された機械学習アルゴリズムは、タンパク質の折り畳み、安定性、機能を予測することを可能にし、実験的試行錯誤を減らしています。企業や研究機関は現在、AI主導の設計ツールをバーチャル・スクリーニングに活用し、物理的にテストされる前にタンパク質構造を最適化することができます。これは創薬において非常に貴重であり、AIはタンパク質の標的を迅速に特定し、治療薬の開発を加速させるのに役立っています。さらに、機械学習は、特定の特性を持つタンパク質を進化させるために自然淘汰を模倣するプロセスである定向進化の利用を促進しています。この技術をAIベースの予測モデリングと組み合わせることで、科学者はタンパク質の効率と安定性を飛躍的に高めることができます。タンパク質工学におけるAIと機械学習の統合は、タンパク質の改変の精度を向上させるだけでなく、新規タンパク質の迅速な開発を可能にし、この分野における科学的発見へのアプローチに革命をもたらします。

タンパク質工学市場の成長はいくつかの要因によって牽引される

タンパク質工学市場の成長は、技術の進歩、最終用途の拡大、消費者の需要の進化など、いくつかの要因によって牽引されています。CRISPR遺伝子編集、ハイスループットスクリーニング、AIを活用した予測モデリングなどの技術革新により、特定の機能を持つタンパク質の設計が容易になり、創薬、診断、産業用途に新たな道が開かれつつあります。医薬品、農業、飲食品、環境科学などの最終用途産業では、疾患治療、持続可能な生産、環境浄化のためのオーダーメイドのソリューションを提供するため、人工タンパク質の採用が増加しています。例えば、製薬業界における生物製剤の需要の高まりは、特に腫瘍学や免疫学などの分野において、より効果的で副作用の少ない疾患をターゲットとすることができる人工タンパク質へのニーズを後押ししています。さらに、持続可能で環境に優しい製品に対する消費者の関心は、生分解性包装から植物由来の代替食品に至るまで、日常製品に使用される生物工学的タンパク質の開発を促しています。環境科学の分野では、汚染物質を分解したり、温室効果ガスを捕捉したりするように設計されたタンパク質が、気候変動緩和の取り組みに応用されています。さらに、個別化医療の台頭と精密診断の推進は、患者固有の治療法や診断法における人工タンパク質の使用を加速させ、市場の可能性をさらに拡大させています。このような動向は、世界の課題と消費者の期待の両方に対応する上で、タンパク質工学が変革的な役割を果たすことを明確にし、多方面にわたるタンパク質工学の成長に拍車をかけています。

セグメント

製品（装置、試薬、ソフトウェア &サービス）;テクノロジー（合理的タンパク質設計、誘導進化、ハイブリッドアプローチ）;エンドユース（製薬&バイオテクノロジー企業、契約研究機関、学術研究機関）

調査対象企業の例（注目の18社）

  • Abzena, Ltd.
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Bruker Corporation
  • Codexis, Inc.
  • Creative Biolabs
  • Danaher Corporation
  • Enantis S.R.O.
  • GE Healthcare
  • Genscript Biotech Corporation
  • Innovagen AB
  • Merck KGaA
  • New England Biolabs, Inc.
  • Perkinelmer, Inc.
  • Phynexus, Inc.（A Part of Biotage）
  • Promega Corporation
  • Proteogenix
  • Takara Bio, Inc.
  • Thermo Fisher Scientific, Inc.
  • Waters Corporation

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP22659

Global Protein Engineering Market to Reach US$7.8 Billion by 2030

The global market for Protein Engineering estimated at US$3.0 Billion in the year 2023, is expected to reach US$7.8 Billion by 2030, growing at a CAGR of 14.5% over the analysis period 2023-2030. Protein Engineering Instruments, one of the segments analyzed in the report, is expected to record a 13.8% CAGR and reach US$3.3 Billion by the end of the analysis period. Growth in the Protein Engineering Reagents segment is estimated at 14.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$779.9 Million While China is Forecast to Grow at 18.9% CAGR

The Protein Engineering market in the U.S. is estimated at US$779.9 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$2.0 Billion by the year 2030 trailing a CAGR of 18.9% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 10.0% and 12.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 10.9% CAGR.

Global Protein Engineering Market - Key Trends & Drivers Summarized

How Is Protein Engineering Shaping the Future of Biopharmaceuticals?

Protein engineering is revolutionizing biopharmaceuticals by enabling the development of tailored therapeutic proteins with enhanced effectiveness, stability, and target specificity. By manipulating protein structures, scientists can create monoclonal antibodies, enzymes, and other therapeutic proteins with optimized properties for treating specific diseases. Monoclonal antibodies, for instance, have become invaluable in the fight against cancer, autoimmune diseases, and infectious diseases, providing targeted therapies that reduce off-target effects and improve patient outcomes. Similarly, enzyme replacement therapies, another application of protein engineering, are essential for treating genetic disorders like Gaucher’s disease and Fabry disease. Protein engineering’s impact on vaccine development is also significant, with engineered proteins being used in vaccines against viral threats, enhancing immune response and stability in various delivery formats. The potential to customize proteins on a molecular level has positioned protein engineering as a cornerstone of precision medicine, where treatments are increasingly tailored to an individual's genetic makeup, increasing therapeutic success and reducing side effects. As biopharmaceutical companies continue to seek targeted therapies, protein engineering is at the forefront, helping bring innovative drugs and therapies to market faster and with improved efficacy.

What Role Does Synthetic Biology Play in Protein Engineering Innovation?

Synthetic biology has become a powerful tool within protein engineering, allowing researchers to design proteins with novel functionalities that meet specific industrial, environmental, and medical needs. Advances in gene-editing technologies like CRISPR and TALEN have made it easier to modify protein structures precisely, creating new capabilities and expanding protein engineering’s applications. Synthetic biology has also propelled the development of sustainable enzymes used in industrial processes, replacing harsh chemicals with environmentally friendly biocatalysts. For instance, engineered enzymes are now widely used in the textile, detergent, and biofuel industries, where they help reduce energy consumption, lower waste production, and improve efficiency. Moreover, by incorporating computational models and high-throughput screening, synthetic biology enables scientists to create proteins that exhibit enhanced stability and functionality under challenging conditions, such as extreme temperatures or pH levels. These engineered proteins are also proving valuable in environmental cleanup, where proteins designed to degrade pollutants or capture carbon dioxide are being deployed to mitigate environmental damage. The synergy between synthetic biology and protein engineering is expanding the possibilities for innovation, allowing proteins to be designed for virtually any application imaginable, making them indispensable across industries.

How Are AI and Machine Learning Transforming Protein Engineering?

AI and machine learning are transforming protein engineering by significantly speeding up the design and optimization processes. Traditionally, protein engineering was a time-intensive field, requiring countless iterations to achieve desired protein properties. However, the introduction of AI algorithms has dramatically reduced this complexity by using data-driven predictions to model protein behavior, enabling researchers to foresee structural interactions and modifications with remarkable accuracy. Machine learning algorithms trained on protein data have made it possible to predict protein folding, stability, and function, thus reducing experimental trial and error. Companies and research institutions are now able to utilize AI-driven design tools for virtual screening, optimizing protein structures before they are ever physically tested. This has proved invaluable in drug discovery, where AI helps identify protein targets quickly, accelerating the development of therapeutics. Additionally, machine learning is facilitating the use of directed evolution, a process that mimics natural selection to evolve proteins with specific characteristics. This technique, when combined with AI-based predictive modeling, allows scientists to enhance proteins’ efficiency and stability exponentially. The integration of AI and machine learning in protein engineering not only improves the accuracy of protein modifications but also enables the rapid development of novel proteins, revolutionizing the approach to scientific discovery in this field.

The Growth in the Protein Engineering Market Is Driven by Several Factors…

The growth in the protein engineering market is driven by several factors, including advances in technology, expanding end-use applications, and evolving consumer demands. Technological innovations such as CRISPR gene editing, high-throughput screening, and AI-powered predictive modeling are making it easier to design proteins with specific functions, opening new avenues in drug discovery, diagnostics, and industrial applications. End-use industries like pharmaceuticals, agriculture, food and beverage, and environmental science are increasingly adopting engineered proteins, as they offer tailored solutions for disease treatment, sustainable production, and environmental cleanup. For example, the growing demand for biologics in the pharmaceutical industry is driving the need for engineered proteins that can target diseases more effectively and with fewer side effects, particularly in fields like oncology and immunology. Additionally, consumer interest in sustainable and eco-friendly products is encouraging the development of bioengineered proteins for use in everyday products, from biodegradable packaging to plant-based food alternatives. In environmental science, proteins engineered to degrade pollutants or capture greenhouse gases are finding applications in climate change mitigation efforts. Furthermore, the rise of personalized medicine and the push for precision diagnostics are accelerating the use of engineered proteins in patient-specific therapies and diagnostics, further expanding the market’s potential. These converging trends underscore the transformative role of protein engineering in addressing both global challenges and consumer expectations, fueling its growth across multiple sectors.

SCOPE OF STUDY:

The report analyzes the Protein Engineering market in terms of US$ Thousand by the following End-Use; Product; Technology, and Geographic Regions/Countries:

Segments:

Product (Instruments, Reagents, Software & Services); Technology (Rational Protein Design, Directed Evolution, Hybrid Approach); End-Use (Pharma & Biotech Companies, Contract Research Organizations, Academic Research Institutes)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 18 Featured) -

  • Abzena, Ltd.
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Bruker Corporation
  • Codexis, Inc.
  • Creative Biolabs
  • Danaher Corporation
  • Enantis S.R.O.
  • GE Healthcare
  • Genscript Biotech Corporation
  • Innovagen AB
  • Merck KGaA
  • New England Biolabs, Inc.
  • Perkinelmer, Inc.
  • Phynexus, Inc. (A Part of Biotage)
  • Promega Corporation
  • Proteogenix
  • Takara Bio, Inc.
  • Thermo Fisher Scientific, Inc.
  • Waters Corporation

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Protein Engineering - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Therapeutic Proteins in Biopharmaceuticals Drives Growth in Protein Engineering Solutions
    • Increased Focus on Precision Medicine Spurs Development of Customized and Targeted Protein Therapies
    • Advances in CRISPR and Gene Editing Technologies Expand Capabilities in Protein Engineering for Disease Treatment
    • Growth of Monoclonal Antibodies and Enzyme Replacement Therapies Elevates Market for Engineered Proteins
    • Increased Use of Protein Engineering in Vaccine Development Supports Market, Especially for Viral Disease Prevention
    • Rising Investment in Synthetic Biology Enhances Market for Engineered Proteins with Novel Functionalities
    • Expansion of Structural Biology and Computational Modeling Improves Accuracy and Efficiency in Protein Design
    • High Demand for Sustainable Industrial Enzymes Spurs Development of Engineered Proteins for Industrial Applications
    • Increased Focus on Biocatalysis in Pharmaceutical Manufacturing Drives Use of Custom Enzymes and Proteins
    • Growth in Agricultural Biotechnology Fuels Demand for Engineered Proteins in Crop Protection and Yield Enhancement
    • Advances in AI and Machine Learning Enhance Predictive Modeling for Protein Function and Stability
    • Rising Demand for Protein-Based Biosensors and Diagnostic Tools Expands Applications in Clinical and Environmental Testing
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Rational Protein Design by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Rational Protein Design by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Rational Protein Design by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Directed Evolution by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Directed Evolution by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Directed Evolution by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Hybrid Approach by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Hybrid Approach by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Hybrid Approach by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Contract Research Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Contract Research Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Contract Research Organizations by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Academic Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Academic Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Academic Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 19: World Protein Engineering Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Protein Engineering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Protein Engineering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Protein Engineering by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Software & Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Software & Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: World 16-Year Perspective for Software & Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Protein Engineering Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Protein Engineering by Technology - Percentage Breakdown of Value Sales for Rational Protein Design, Directed Evolution and Hybrid Approach for the Years 2014, 2024 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Protein Engineering by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Protein Engineering by Product - Instruments, Reagents and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Protein Engineering by Product - Instruments, Reagents and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: USA 16-Year Perspective for Protein Engineering by Product - Percentage Breakdown of Value Sales for Instruments, Reagents and Software & Services for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: Canada 16-Year Perspective for Protein Engineering by Technology - Percentage Breakdown of Value Sales for Rational Protein Design, Directed Evolution and Hybrid Approach for the Years 2014, 2024 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for Protein Engineering by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Protein Engineering by Product - Instruments, Reagents and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Protein Engineering by Product - Instruments, Reagents and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Canada 16-Year Perspective for Protein Engineering by Product - Percentage Breakdown of Value Sales for Instruments, Reagents and Software & Services for the Years 2014, 2024 & 2030
  • JAPAN
    • Protein Engineering Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Japan 16-Year Perspective for Protein Engineering by Technology - Percentage Breakdown of Value Sales for Rational Protein Design, Directed Evolution and Hybrid Approach for the Years 2014, 2024 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: Japan 16-Year Perspective for Protein Engineering by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Protein Engineering by Product - Instruments, Reagents and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Protein Engineering by Product - Instruments, Reagents and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: Japan 16-Year Perspective for Protein Engineering by Product - Percentage Breakdown of Value Sales for Instruments, Reagents and Software & Services for the Years 2014, 2024 & 2030
  • CHINA
    • Protein Engineering Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 59: China Recent Past, Current & Future Analysis for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: China 16-Year Perspective for Protein Engineering by Technology - Percentage Breakdown of Value Sales for Rational Protein Design, Directed Evolution and Hybrid Approach for the Years 2014, 2024 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: China 16-Year Perspective for Protein Engineering by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 65: China Recent Past, Current & Future Analysis for Protein Engineering by Product - Instruments, Reagents and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Protein Engineering by Product - Instruments, Reagents and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: China 16-Year Perspective for Protein Engineering by Product - Percentage Breakdown of Value Sales for Instruments, Reagents and Software & Services for the Years 2014, 2024 & 2030
  • EUROPE
    • Protein Engineering Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: Europe 16-Year Perspective for Protein Engineering by Technology - Percentage Breakdown of Value Sales for Rational Protein Design, Directed Evolution and Hybrid Approach for the Years 2014, 2024 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: Europe 16-Year Perspective for Protein Engineering by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Protein Engineering by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Protein Engineering by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: Europe 16-Year Perspective for Protein Engineering by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Protein Engineering by Product - Instruments, Reagents and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Protein Engineering by Product - Instruments, Reagents and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: Europe 16-Year Perspective for Protein Engineering by Product - Percentage Breakdown of Value Sales for Instruments, Reagents and Software & Services for the Years 2014, 2024 & 2030
  • FRANCE
    • Protein Engineering Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 80: France Recent Past, Current & Future Analysis for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: France 16-Year Perspective for Protein Engineering by Technology - Percentage Breakdown of Value Sales for Rational Protein Design, Directed Evolution and Hybrid Approach for the Years 2014, 2024 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: France 16-Year Perspective for Protein Engineering by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for Protein Engineering by Product - Instruments, Reagents and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Protein Engineering by Product - Instruments, Reagents and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: France 16-Year Perspective for Protein Engineering by Product - Percentage Breakdown of Value Sales for Instruments, Reagents and Software & Services for the Years 2014, 2024 & 2030
  • GERMANY
    • Protein Engineering Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Germany 16-Year Perspective for Protein Engineering by Technology - Percentage Breakdown of Value Sales for Rational Protein Design, Directed Evolution and Hybrid Approach for the Years 2014, 2024 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Germany 16-Year Perspective for Protein Engineering by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Protein Engineering by Product - Instruments, Reagents and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Protein Engineering by Product - Instruments, Reagents and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Germany 16-Year Perspective for Protein Engineering by Product - Percentage Breakdown of Value Sales for Instruments, Reagents and Software & Services for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Italy 16-Year Perspective for Protein Engineering by Technology - Percentage Breakdown of Value Sales for Rational Protein Design, Directed Evolution and Hybrid Approach for the Years 2014, 2024 & 2030
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: Italy 16-Year Perspective for Protein Engineering by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Protein Engineering by Product - Instruments, Reagents and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Protein Engineering by Product - Instruments, Reagents and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: Italy 16-Year Perspective for Protein Engineering by Product - Percentage Breakdown of Value Sales for Instruments, Reagents and Software & Services for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Protein Engineering Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 107: UK Recent Past, Current & Future Analysis for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: UK 16-Year Perspective for Protein Engineering by Technology - Percentage Breakdown of Value Sales for Rational Protein Design, Directed Evolution and Hybrid Approach for the Years 2014, 2024 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 112: UK 16-Year Perspective for Protein Engineering by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 113: UK Recent Past, Current & Future Analysis for Protein Engineering by Product - Instruments, Reagents and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Protein Engineering by Product - Instruments, Reagents and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 115: UK 16-Year Perspective for Protein Engineering by Product - Percentage Breakdown of Value Sales for Instruments, Reagents and Software & Services for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 116: Spain Recent Past, Current & Future Analysis for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 117: Spain Historic Review for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 118: Spain 16-Year Perspective for Protein Engineering by Technology - Percentage Breakdown of Value Sales for Rational Protein Design, Directed Evolution and Hybrid Approach for the Years 2014, 2024 & 2030
    • TABLE 119: Spain Recent Past, Current & Future Analysis for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Spain Historic Review for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 121: Spain 16-Year Perspective for Protein Engineering by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 122: Spain Recent Past, Current & Future Analysis for Protein Engineering by Product - Instruments, Reagents and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Spain Historic Review for Protein Engineering by Product - Instruments, Reagents and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 124: Spain 16-Year Perspective for Protein Engineering by Product - Percentage Breakdown of Value Sales for Instruments, Reagents and Software & Services for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 125: Russia Recent Past, Current & Future Analysis for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Russia Historic Review for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 127: Russia 16-Year Perspective for Protein Engineering by Technology - Percentage Breakdown of Value Sales for Rational Protein Design, Directed Evolution and Hybrid Approach for the Years 2014, 2024 & 2030
    • TABLE 128: Russia Recent Past, Current & Future Analysis for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Russia Historic Review for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 130: Russia 16-Year Perspective for Protein Engineering by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 131: Russia Recent Past, Current & Future Analysis for Protein Engineering by Product - Instruments, Reagents and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Russia Historic Review for Protein Engineering by Product - Instruments, Reagents and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 133: Russia 16-Year Perspective for Protein Engineering by Product - Percentage Breakdown of Value Sales for Instruments, Reagents and Software & Services for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Rest of Europe Historic Review for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 136: Rest of Europe 16-Year Perspective for Protein Engineering by Technology - Percentage Breakdown of Value Sales for Rational Protein Design, Directed Evolution and Hybrid Approach for the Years 2014, 2024 & 2030
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 139: Rest of Europe 16-Year Perspective for Protein Engineering by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Protein Engineering by Product - Instruments, Reagents and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Rest of Europe Historic Review for Protein Engineering by Product - Instruments, Reagents and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 142: Rest of Europe 16-Year Perspective for Protein Engineering by Product - Percentage Breakdown of Value Sales for Instruments, Reagents and Software & Services for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Protein Engineering Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 145: Asia-Pacific 16-Year Perspective for Protein Engineering by Technology - Percentage Breakdown of Value Sales for Rational Protein Design, Directed Evolution and Hybrid Approach for the Years 2014, 2024 & 2030
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 148: Asia-Pacific 16-Year Perspective for Protein Engineering by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Protein Engineering by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Protein Engineering by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 151: Asia-Pacific 16-Year Perspective for Protein Engineering by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Protein Engineering by Product - Instruments, Reagents and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Protein Engineering by Product - Instruments, Reagents and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 154: Asia-Pacific 16-Year Perspective for Protein Engineering by Product - Percentage Breakdown of Value Sales for Instruments, Reagents and Software & Services for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Protein Engineering Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 155: Australia Recent Past, Current & Future Analysis for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Australia Historic Review for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 157: Australia 16-Year Perspective for Protein Engineering by Technology - Percentage Breakdown of Value Sales for Rational Protein Design, Directed Evolution and Hybrid Approach for the Years 2014, 2024 & 2030
    • TABLE 158: Australia Recent Past, Current & Future Analysis for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Australia Historic Review for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 160: Australia 16-Year Perspective for Protein Engineering by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 161: Australia Recent Past, Current & Future Analysis for Protein Engineering by Product - Instruments, Reagents and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Australia Historic Review for Protein Engineering by Product - Instruments, Reagents and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 163: Australia 16-Year Perspective for Protein Engineering by Product - Percentage Breakdown of Value Sales for Instruments, Reagents and Software & Services for the Years 2014, 2024 & 2030
  • INDIA
    • Protein Engineering Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 164: India Recent Past, Current & Future Analysis for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 165: India Historic Review for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 166: India 16-Year Perspective for Protein Engineering by Technology - Percentage Breakdown of Value Sales for Rational Protein Design, Directed Evolution and Hybrid Approach for the Years 2014, 2024 & 2030
    • TABLE 167: India Recent Past, Current & Future Analysis for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 168: India Historic Review for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 169: India 16-Year Perspective for Protein Engineering by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 170: India Recent Past, Current & Future Analysis for Protein Engineering by Product - Instruments, Reagents and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 171: India Historic Review for Protein Engineering by Product - Instruments, Reagents and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 172: India 16-Year Perspective for Protein Engineering by Product - Percentage Breakdown of Value Sales for Instruments, Reagents and Software & Services for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 173: South Korea Recent Past, Current & Future Analysis for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 174: South Korea Historic Review for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 175: South Korea 16-Year Perspective for Protein Engineering by Technology - Percentage Breakdown of Value Sales for Rational Protein Design, Directed Evolution and Hybrid Approach for the Years 2014, 2024 & 2030
    • TABLE 176: South Korea Recent Past, Current & Future Analysis for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 177: South Korea Historic Review for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 178: South Korea 16-Year Perspective for Protein Engineering by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 179: South Korea Recent Past, Current & Future Analysis for Protein Engineering by Product - Instruments, Reagents and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 180: South Korea Historic Review for Protein Engineering by Product - Instruments, Reagents and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 181: South Korea 16-Year Perspective for Protein Engineering by Product - Percentage Breakdown of Value Sales for Instruments, Reagents and Software & Services for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Rest of Asia-Pacific Historic Review for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 184: Rest of Asia-Pacific 16-Year Perspective for Protein Engineering by Technology - Percentage Breakdown of Value Sales for Rational Protein Design, Directed Evolution and Hybrid Approach for the Years 2014, 2024 & 2030
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 16-Year Perspective for Protein Engineering by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Protein Engineering by Product - Instruments, Reagents and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Rest of Asia-Pacific Historic Review for Protein Engineering by Product - Instruments, Reagents and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 190: Rest of Asia-Pacific 16-Year Perspective for Protein Engineering by Product - Percentage Breakdown of Value Sales for Instruments, Reagents and Software & Services for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Protein Engineering Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 191: Latin America Recent Past, Current & Future Analysis for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Latin America Historic Review for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 193: Latin America 16-Year Perspective for Protein Engineering by Technology - Percentage Breakdown of Value Sales for Rational Protein Design, Directed Evolution and Hybrid Approach for the Years 2014, 2024 & 2030
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 196: Latin America 16-Year Perspective for Protein Engineering by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Protein Engineering by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Protein Engineering by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 199: Latin America 16-Year Perspective for Protein Engineering by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Protein Engineering by Product - Instruments, Reagents and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for Protein Engineering by Product - Instruments, Reagents and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 202: Latin America 16-Year Perspective for Protein Engineering by Product - Percentage Breakdown of Value Sales for Instruments, Reagents and Software & Services for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 203: Argentina Recent Past, Current & Future Analysis for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Argentina Historic Review for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 205: Argentina 16-Year Perspective for Protein Engineering by Technology - Percentage Breakdown of Value Sales for Rational Protein Design, Directed Evolution and Hybrid Approach for the Years 2014, 2024 & 2030
    • TABLE 206: Argentina Recent Past, Current & Future Analysis for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Argentina Historic Review for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 208: Argentina 16-Year Perspective for Protein Engineering by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 209: Argentina Recent Past, Current & Future Analysis for Protein Engineering by Product - Instruments, Reagents and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 210: Argentina Historic Review for Protein Engineering by Product - Instruments, Reagents and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 211: Argentina 16-Year Perspective for Protein Engineering by Product - Percentage Breakdown of Value Sales for Instruments, Reagents and Software & Services for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 212: Brazil Recent Past, Current & Future Analysis for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 213: Brazil Historic Review for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 214: Brazil 16-Year Perspective for Protein Engineering by Technology - Percentage Breakdown of Value Sales for Rational Protein Design, Directed Evolution and Hybrid Approach for the Years 2014, 2024 & 2030
    • TABLE 215: Brazil Recent Past, Current & Future Analysis for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 216: Brazil Historic Review for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 217: Brazil 16-Year Perspective for Protein Engineering by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 218: Brazil Recent Past, Current & Future Analysis for Protein Engineering by Product - Instruments, Reagents and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 219: Brazil Historic Review for Protein Engineering by Product - Instruments, Reagents and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 220: Brazil 16-Year Perspective for Protein Engineering by Product - Percentage Breakdown of Value Sales for Instruments, Reagents and Software & Services for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 221: Mexico Recent Past, Current & Future Analysis for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 222: Mexico Historic Review for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 223: Mexico 16-Year Perspective for Protein Engineering by Technology - Percentage Breakdown of Value Sales for Rational Protein Design, Directed Evolution and Hybrid Approach for the Years 2014, 2024 & 2030
    • TABLE 224: Mexico Recent Past, Current & Future Analysis for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 225: Mexico Historic Review for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 226: Mexico 16-Year Perspective for Protein Engineering by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 227: Mexico Recent Past, Current & Future Analysis for Protein Engineering by Product - Instruments, Reagents and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 228: Mexico Historic Review for Protein Engineering by Product - Instruments, Reagents and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 229: Mexico 16-Year Perspective for Protein Engineering by Product - Percentage Breakdown of Value Sales for Instruments, Reagents and Software & Services for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 231: Rest of Latin America Historic Review for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 232: Rest of Latin America 16-Year Perspective for Protein Engineering by Technology - Percentage Breakdown of Value Sales for Rational Protein Design, Directed Evolution and Hybrid Approach for the Years 2014, 2024 & 2030
    • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 234: Rest of Latin America Historic Review for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 235: Rest of Latin America 16-Year Perspective for Protein Engineering by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Protein Engineering by Product - Instruments, Reagents and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 237: Rest of Latin America Historic Review for Protein Engineering by Product - Instruments, Reagents and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 238: Rest of Latin America 16-Year Perspective for Protein Engineering by Product - Percentage Breakdown of Value Sales for Instruments, Reagents and Software & Services for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Protein Engineering Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 239: Middle East Recent Past, Current & Future Analysis for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 240: Middle East Historic Review for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 241: Middle East 16-Year Perspective for Protein Engineering by Technology - Percentage Breakdown of Value Sales for Rational Protein Design, Directed Evolution and Hybrid Approach for the Years 2014, 2024 & 2030
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 244: Middle East 16-Year Perspective for Protein Engineering by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Protein Engineering by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Protein Engineering by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 247: Middle East 16-Year Perspective for Protein Engineering by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Protein Engineering by Product - Instruments, Reagents and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for Protein Engineering by Product - Instruments, Reagents and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 250: Middle East 16-Year Perspective for Protein Engineering by Product - Percentage Breakdown of Value Sales for Instruments, Reagents and Software & Services for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 251: Iran Recent Past, Current & Future Analysis for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 252: Iran Historic Review for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 253: Iran 16-Year Perspective for Protein Engineering by Technology - Percentage Breakdown of Value Sales for Rational Protein Design, Directed Evolution and Hybrid Approach for the Years 2014, 2024 & 2030
    • TABLE 254: Iran Recent Past, Current & Future Analysis for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 255: Iran Historic Review for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 256: Iran 16-Year Perspective for Protein Engineering by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 257: Iran Recent Past, Current & Future Analysis for Protein Engineering by Product - Instruments, Reagents and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 258: Iran Historic Review for Protein Engineering by Product - Instruments, Reagents and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 259: Iran 16-Year Perspective for Protein Engineering by Product - Percentage Breakdown of Value Sales for Instruments, Reagents and Software & Services for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 260: Israel Recent Past, Current & Future Analysis for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 261: Israel Historic Review for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 262: Israel 16-Year Perspective for Protein Engineering by Technology - Percentage Breakdown of Value Sales for Rational Protein Design, Directed Evolution and Hybrid Approach for the Years 2014, 2024 & 2030
    • TABLE 263: Israel Recent Past, Current & Future Analysis for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 264: Israel Historic Review for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 265: Israel 16-Year Perspective for Protein Engineering by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 266: Israel Recent Past, Current & Future Analysis for Protein Engineering by Product - Instruments, Reagents and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 267: Israel Historic Review for Protein Engineering by Product - Instruments, Reagents and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 268: Israel 16-Year Perspective for Protein Engineering by Product - Percentage Breakdown of Value Sales for Instruments, Reagents and Software & Services for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 270: Saudi Arabia Historic Review for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 271: Saudi Arabia 16-Year Perspective for Protein Engineering by Technology - Percentage Breakdown of Value Sales for Rational Protein Design, Directed Evolution and Hybrid Approach for the Years 2014, 2024 & 2030
    • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 273: Saudi Arabia Historic Review for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 274: Saudi Arabia 16-Year Perspective for Protein Engineering by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Protein Engineering by Product - Instruments, Reagents and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 276: Saudi Arabia Historic Review for Protein Engineering by Product - Instruments, Reagents and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 277: Saudi Arabia 16-Year Perspective for Protein Engineering by Product - Percentage Breakdown of Value Sales for Instruments, Reagents and Software & Services for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 278: UAE Recent Past, Current & Future Analysis for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 279: UAE Historic Review for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 280: UAE 16-Year Perspective for Protein Engineering by Technology - Percentage Breakdown of Value Sales for Rational Protein Design, Directed Evolution and Hybrid Approach for the Years 2014, 2024 & 2030
    • TABLE 281: UAE Recent Past, Current & Future Analysis for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 282: UAE Historic Review for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 283: UAE 16-Year Perspective for Protein Engineering by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 284: UAE Recent Past, Current & Future Analysis for Protein Engineering by Product - Instruments, Reagents and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 285: UAE Historic Review for Protein Engineering by Product - Instruments, Reagents and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 286: UAE 16-Year Perspective for Protein Engineering by Product - Percentage Breakdown of Value Sales for Instruments, Reagents and Software & Services for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 288: Rest of Middle East Historic Review for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 289: Rest of Middle East 16-Year Perspective for Protein Engineering by Technology - Percentage Breakdown of Value Sales for Rational Protein Design, Directed Evolution and Hybrid Approach for the Years 2014, 2024 & 2030
    • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 291: Rest of Middle East Historic Review for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 292: Rest of Middle East 16-Year Perspective for Protein Engineering by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Protein Engineering by Product - Instruments, Reagents and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 294: Rest of Middle East Historic Review for Protein Engineering by Product - Instruments, Reagents and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 295: Rest of Middle East 16-Year Perspective for Protein Engineering by Product - Percentage Breakdown of Value Sales for Instruments, Reagents and Software & Services for the Years 2014, 2024 & 2030
  • AFRICA
    • Protein Engineering Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 296: Africa Recent Past, Current & Future Analysis for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 297: Africa Historic Review for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 298: Africa 16-Year Perspective for Protein Engineering by Technology - Percentage Breakdown of Value Sales for Rational Protein Design, Directed Evolution and Hybrid Approach for the Years 2014, 2024 & 2030
    • TABLE 299: Africa Recent Past, Current & Future Analysis for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 300: Africa Historic Review for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 301: Africa 16-Year Perspective for Protein Engineering by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 302: Africa Recent Past, Current & Future Analysis for Protein Engineering by Product - Instruments, Reagents and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 303: Africa Historic Review for Protein Engineering by Product - Instruments, Reagents and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 304: Africa 16-Year Perspective for Protein Engineering by Product - Percentage Breakdown of Value Sales for Instruments, Reagents and Software & Services for the Years 2014, 2024 & 2030

IV. COMPETITION